Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001127602-21-031116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-16 | 2021-09-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 778.6K | -1% | $0 |
| DMI | 2021-12-16 | 2021-09-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | +10.0K | 5,000 | New | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | A - Grant | $0.00 | +123.0K | 901.6K | +16% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | A - Grant | $0.00 | +574.5K | 574.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | G | D | 5,000 | $0.00 | 783,602 | D By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust | — | — | |
| 2 | Common | Common Stock | 2021-09-01 | G | D | 5,000 | $0.00 | 778,602 | D By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust | — | — | |
| 3 | Common | Common Stock | 2021-09-01 | G | A | 5,000 | $0.00 | 5,000 | I | — | — | |
| 4 | Common | Common Stock | 2021-09-01 | G | A | 5,000 | $0.00 | 5,000 | I | — | — | |
| 5 | Common | Common Stock | 2021-12-14 | A | A | 123,000 | $0.00 | 901,602 | D | — | — | (F3) Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. |
| 6 | Derivative | Emp. Stock Option (Right to Buy) | 2021-12-14 | A | A | 574,500 | $0.00 | 574,500 | D | $11.43 · 2022-12-14 to 2031-12-14 | 574,500 Common Stock | (F4) Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. |